Document:

<PAGE>   1
                                                                    EXHIBIT 10.1

[RNETHEALTH LOGO]

January 10, 2000

Wendy Borow-Johnson
2275 Half Day Road,
Suite 350
Bannockburn, IL 60015-1277
Tel: 847/615-0431
Fax: 847/615-0432

        RE:    EMPLOYMENT LETTER

Dear Wendy:

On behalf of the Board of Directors, I am pleased to offer you a position with
RnetHealth.com, Inc. (the "Company") as its President, commencing immediately
upon execution of this Employment letter, after having been approved for this
position by the Board of Directors on December 9, 1999. Your salary and certain
other terms and conditions of your employment are set out on the attached hereto
as EXHIBIT A.

You should be aware that your employment with the Company, as more fully
described in EXHIBIT A, constitutes "at will" employment. As a result, you are
free to resign at any time, for any reason or for no reason. Similarly, the
Company is free to conclude its employment relationship with you at any time,
with or without cause.

As express conditions of your employment, you agree, represent and warrant that:

        (1)     you will devote your best efforts to the interests of the
                Company and will not engage in other employment or in any
                activities detrimental to the best interests of the Company
                without the prior written consent of the Company;

        (2)     in addition to any specific task described in EXHIBIT A, during
                your period of employment with the Company, you will perform for
                the Company such other duties as may be designated by the
                Company from time to time;

        (3)     you have been notified regarding the Company's policies against
                all forms of racial and sexual discrimination and against sexual
                harassment and agree that during the term of your employment you
                will abide faithfully by such policies and by all Company rules,
                regulations and policies provided to you by the Company; and,

        (4)     you have not prior to the date hereof and will not during the
                term of your employment breach any agreement to keep in
                confidence proprietary information, knowledge or data you
                acquired in confidence or in trust prior to becoming an employee
                of the Company, and you have not previously and will not at any
                future time disclose to the Company, use in the Company's
                business, or induce or cause Company to use, any confidential or
                proprietary information or material belonging to others.

For purposes of federal immigration law, you will be required to provide to the
Company documentary evidence of your identity and eligibility for employment in
the United States. Such documentation must be provided to us within three (3)
business days of your date of hire, or our employment relationship with you may
be terminated.

If you accept this offer, please return to our offices a signed copy of this
agreement. By signing this employment letter, you are certifying and
acknowledging that you have carefully read all of the terms and provisions of
this employment letter and the ND&I Agreement, and that you will fully and
faithfully comply will all such terms and provisions.

 RnetHealth, Inc. - 506 Santa Monica Blvd. - Suite 400 - Santa Monica, CA 90401
          tel (310).393.3979 - fax (310).393.5749 - www.rnethealth.com

<PAGE>   2

Employment Letter
Page 2 of 4

To indicate your acceptance of the Company's offer, please sign and date this
letter in the space provided below and return it to our offices. A duplicate
original is enclosed for your records. This letter, along with the agreement
relating to proprietary rights between you and the Company, sets forth the terms
of your employment with the Company and supersedes any prior representations or
agreements, whether written or oral. This letter may not be modified or amended
except by a written agreement, signed by the Company and by you.

Sincerely,

RNETHEALTH.COM, INC.

--------------------------------------------
William D. Moses
Chief Executive Officer

ACCEPTED AND AGREED TO
this_____day of___________, 19__

---------------------------------------------
Wendy Borow-Johnson

<PAGE>   3
Employment Letter Page 3 of 4
<TABLE>
<CAPTION>

                                    EXHIBIT A
-------------------------------------------------------------------------------------------
<S>                        <C>
JOB TITLE                  President
-------------------------------------------------------------------------------------------
JOB DESCRIPTION            Employee shall report to and be responsible directly
                           to William Moses, the Company's Chief Executive
                           Officer, and shall have and perform such duties and
                           responsibilities relating to the business and
                           operations of Company as may be appropriate to
                           Employee's position and as the Board of Directors
                           from time to time shall assign to her.
-------------------------------------------------------------------------------------------
EXCLUSIVITY                Employee acknowledges that Company has retained
                           Employee and Employee's services for the exclusive
                           benefit of the Company and that Employee will not
                           render her time or services to any other entity
                           without Company's prior written consent. Employee and
                           Company have previously agreed that Employee's work
                           with E! Healthcare is excluded from this provision.
-------------------------------------------------------------------------------------------
EMPLOYMENT TERM            The employment relationship between Employee and
                           Company is "at-will". There is no fixed term of
                           employment. Employee shall assume the
                           responsibilities as Chief Executive Officer immediately.
-------------------------------------------------------------------------------------------
TERMINATION                Notwithstanding the above, employment may be
                           terminated in the following circumstances:

                           By mutual agreement of the parties, without payment
                           of any severance;

                           By Company, with or without good cause, upon at least
                           thirty (30) days advance written notice, with
                           compensation as calculated through the date of such
                           termination;

                           By Employee, for any reason, upon at least thirty
                           (30) days advance written notice, with compensation
                           as calculated through the date of such termination;

                           For purposes of this Agreement, "good cause" is
                           defined as gross negligence or willful misconduct or,
                           given the nature of the Company's mission, alcohol or
                           substance abuse.
-------------------------------------------------------------------------------------------
SALARY &                   Annual Salary. Employee shall receive an annual salary of
COMPENSATION               $150,000 together with incremental bonuses, which shall commence
                           upon the Company's closing of a permanent financing. The salary
                           will be paid twice monthly in accordance with the Company's
                           standard payroll procedure.

                           Paid Vacation. The Employee will be entitled to three
                           (3) weeks paid vacation for each twelve-month period
                           worked. For a period worked which is less than one
                           year, vacation time shall be prorated.
-------------------------------------------------------------------------------------------
STOCK OPTION               Company shall issue to Employee an option to
                           purchase 1,015,000 shares of common stock at $0.39
                           per share, the closing bid price on December 9, 1999.
                           Vesting of the Option shall begin upon execution of
                           the Employment Agreement and continue to vest
                           thereafter in equal installments monthly for a period
                           of two (2) years. The terms and conditions of the
                           Option shall be more fully described in a Stock
                           Option Agreement.
-------------------------------------------------------------------------------------------
BENEFITS                   Employee will participate in the Company's benefits
                           program. Employee will receive enrollment forms and
                           other benefits information upon acceptance of the
                           offer.
-------------------------------------------------------------------------------------------
TIME COMMITMENT            Employment with the Company shall be on a full-time basis.
                           Employee agrees
-------------------------------------------------------------------------------------------
</TABLE>

<PAGE>   4
Employment Letter
Page 4 of 4

--------------------------------------------------------------------------------
                          to commit to work 3 days in the Santa Monica location.
--------------------------------------------------------------------------------
OTHER TERMS &             None.
CONDITIONS
--------------------------------------------------------------------------------

<PAGE>   5
[RNETHEALTH LOGO]

August 7, 2000

Wendy Borow Johnson
1571 Christina Lane
Lake Forest, IL 60045-3849

        RE:    ADDENDUM TO EMPLOYMENT AGREEMENT DATED JANUARY 10, 2000

Dear Wendy:

This letter confirms our agreement regarding the modification and amendment
("Addendum") to your existing Employment Agreement ("Agreement") with
Rnethealth.com, Inc. ("Company") dated January 10, 2000.

This Addendum and the modifications reflected herein shall be effective as of
July 1, 2000.

Terms used but not defined herein have the meanings ascribed to them in the
Agreement.

--------------------------------------------------------------------------------
JOB TITLE:                 President and Chief Executive Officer
--------------------------------------------------------------------------------
SALARY:                    $250,000 annually subject to any applicable federal
                           and state taxes and/or withholdings. The Company
                           shall pay Employee twice monthly in accordance with
                           the Company's standard payroll procedures.

--------------------------------------------------------------------------------

                  THIS SPACE HAS BEEN INTENTIONALLY LEFT BLANK

 RnetHealth, Inc. - 506 Santa Monica Blvd. - Suite 400 - Santa Monica, CA 90401
         tel (310).393.3979 0 fax (310).393.5749 9 www.rnethealth.com

<PAGE>   6

Wendy Borow Johnson
August 7, 2000
Page 2

--------------------------------------------------------------------------------
EQUITY                     After having been approved by the Board of Directors
CONSIDERATION:             on July 30, 2000, Employee shall receive an Option to
                           purchase 500,000 shares of Rnethealth.com, Inc.
                           common stock (the "Warrant").

                           The Option shall vest, as follows: At the end of Year
                           1,200,000 shares shall vest in Employee with a strike
                           price at $0.50 (the closing stock price on July 30,
                           2000); and, at the end of Year 2 the remaining
                           300,000 shares shall vest in Employee with the strike
                           price to be set at $0.80. All other terms and
                           conditions of Option shall be set forth in an Option
                           Agreement.

                           This Warrant is in addition to the option to purchase
                           1,015,000 shares of common stock previously granted
                           to Employee pursuant to the terms of the January 10,
                           2000 Employment Agreement and the option to purchase
                           200,000 shares for Employee's participation on the
                           Executive Committee.
--------------------------------------------------------------------------------
BONUS:                     Employee shall receive an annual bonus based on the
                           profitability of the Company and other benchmarks,
                           the bonus amount to be determined by the Board of
                           Directors. The benchmarks shall include, but are not
                           limited to, relisting of the Company's common stock
                           on NASDAQ, and/or an average share price over $3.00
                           per share during the last two months of the fiscal
                           year ending June 30, 2001.
--------------------------------------------------------------------------------
TERM:                      The term of employment shall be for two (2) years
                           beginning on July 1, 2000.

                           If the Company terminates the Employee "without
                           cause," the Company shall pay severance to Employee
                           at a rate of compensation equal to six months salary.

                           If the Company terminates the Employee "with cause,"
                           the Company shall compensate Employee as calculated
                           through the date of termination, without payment of
                           any severance.

                           For all purposes under this Agreement, a termination
                           for "cause" shall mean a good faith determination by
                           the Company's Board of Directors that Employee's
                           employment be terminated for any of the following
                           reasons: (I) willful misconduct which materially
                           damages the Company; (ii) misappropriation of the
                           assets of the Company; or (iii) conviction of, or a
                           plea of "guilty" or "no contest" to a felony under
                           the laws of the United States or any
--------------------------------------------------------------------------------

<PAGE>   7

Wendy Borow Johnson
August 7, 2000
Page 3
--------------------------------------------------------------------------------
                           state thereof. A termination of Employee's employment
                           in any other circumstances or for any other reasons
                           will be a termination "without cause."
--------------------------------------------------------------------------------
CHANGE IN CONTROL:         If a change in control (as defined herein) occurs,
                           and the Employee's employment is terminated, such
                           termination will be considered to be a termination
                           "without cause."

                           Under such circumstances, if the Company terminates
                           the Employee "without cause," the Company shall pay
                           severance to Employee at a rate of compensation equal
                           to six months salary.

                           In addition, any then unvested options and/or
                           warrants shall vest immediately, and the Employee
                           shall have at least until the severance due is paid
                           in full to submit payment for any options or warrants
                           that are to be exercised, said period shall not
                           exceed one year.

                           A "change in control" is deemed to have occurred if
                           (a) a "person" (as defined in section 13(d) of the
                           Securities Exchange Act of 1934) becomes the
                           "beneficial owner" (as defined in Rule 13(d)3 under
                           the Securities Exchange Act of 1934) of shares of
                           common stock representing 30 percent or more of the
                           shares as to which votes may be cast for the election
                           of directors of Company or (b) individuals who are
                           directors of the Company at the beginning of a
                           24-month period cease to constitute at least two-
                           thirds of all directors of Company at any time during
                           such period.
--------------------------------------------------------------------------------

ALL OTHER TERMS AND CONDITIONS OF THE AGREEMENT REMAIN UNCHANGED, AND ARE STILL
IN FULL FORCE AND EFFECT.

Please confirm your acceptance and agreement to the foregoing by signing this
Addendum in the space provided below, returning a copy to our offices and
retaining a copy for your records.

<PAGE>   8

Wendy Borow Johnson
August 7, 2000
Page 4

This Addendum and your original Employment Agreement set forth the terms of your
employment with the Company and supersedes any prior representations or
agreements, whether written or oral. This Addendum may not be modified or
amended except by a written agreement, signed by the Company and by you.

Sincerely,

Robert Portrie
Board of Directors, Chairman

ACCEPTED AND AGREED TO THIS_______________DAY OF _____________________, 2000.

EMPLOYEE:

---------------------------------
Wendy Borow Johnson

<PAGE>   9
                                RNETHEALTH, INC.

                             STOCK OPTION AGREEMENT

        Rnethealth.com, Inc., a Colorado corporation (the "Company"), does
hereby grant to WENDY BOROW JOHNSON (the "Optionee") an option (the "Option") to
purchase One Million Fifteen Thousand (1,015,000) shares (the "Shares") of the
Common Stock, par value $.01 per share (the "Common Stock"), of the Company at
$0.39 per Share (the "Option Price"), the closing stock price on December 9,
1999.

        This Option is granted to the Optionee in partial consideration for the
services rendered and to be rendered by the Optionee for the benefit of the
Company and its shareholders as an employee. This Option is not an incentive
option.

1. Term

        This Option shall expire at 5:00 p.m., local time in Santa Monica,
California, on December 9, 2002 or in the event any of the following enumerated
below shall occur. The date determined pursuant to this Section 1 is referred to
herein as the "Expiration Date."

        -   If the Optionee terminates her employment with the Company (other
            than on account of death or disability) or if the Optionee is
            terminated for cause, the Option shall be exercisable only as to
            those shares then vested for up to three (3) months after
            resignation or termination.

        -   If the Optionee terminates the employment relationship on account of
            disability, the option can be exercised for one year after
            termination or, if the remaining term of the option is less than one
            year, until the end of the option term,

         -  If the Optionee's employment is terminated for any other reason than
            on account of disability or death or for cause, any shares remaining
            unvested shall immediately vest and the option can be exercised for
            up to three (3) months after termination of the employment
            relationship, or if the remaining term of the option is less than
            three months, until the end of the option term,

         -  If the option holder dies while employed, in the one-year period
            following termination for disability, or in the three month period
            described in the preceding bullet point, the option holder's
            successors can exercise the option for a year following the date of

<PAGE>   10

            the option holder's death or, if the remaining term of the option is
            shorter, than until the end of the option term.

2. Vesting; Time of Exercise

        This option shall vest in equal installments monthly over a period of
two years (1/24th or 42,291 shares per month) and may be exercised as to any or
all of the Shares then vested from time to time as of the date of grant through
the Expiration Date.

3. Manner of Exercise

        This Option may only be exercised by written notice (the "Exercise
Notice") to the Company at its principal executive offices, to the attention of
its Secretary. The Exercise Notice shall (i) specify the number of Shares with
respect to which the option is being exercised, (ii) contain the express
confirmation by the Optionee of his representations, warranties and covenants
contained in Section 6 hereof, (iii) be signed by the Optionee, (iv) be
accompanied by full payment of the Option Price for the number of Shares
specified in the Exercise Notice and (v) be accompanied by the original executed
copy of this Option. The Company shall deliver to the Optionee a certificate
representing such Shares registered in the name of the Optionee as soon as
practicable following receipt by the Company of (a) advice from its counsel that
the issuance of such Shares and the delivery of such certificates are in
compliance with all applicable laws, rules and regulations of all governmental
authorities and the requirements of any securities exchange or any securities
association on which, or on the facilities of which, shares of the Common Stock
are then listed or traded. If an Exercise Notice relates to fewer than all of
the Shares, the Company shall, at such time as it delivers to the Optionee a
certificate representing the Shares with respect to which this Option is
exercised, deliver a replacement Option on the same terms and conditions as this
Option with respect to all remaining Shares.

4. Payment

        Payment of the Option Price shall be made, at the election of the
Optionee, (i) in cash; or (ii) by certified or bank cashier's check or other
check acceptable to the Company, payable to the Company's order; or (iii) by
delivery to the Company of shares of Common Stock owned by the Optionee for

                                       2
<PAGE>   11

not less than six (6) months, duly endorsed for transfer, with a fair market
value, determined by the Board, equal to the Option Price; or (iv) by any
combination of (i),(ii) and (iii); or (v) if the Shares shall have been
registered under the Securities Act of 1933, as amended (the "Act") by delivery
to the Company of a copy of irrevocable instructions to a broker to deliver to
the Company promptly an amount from the proceeds of the sale of all or part of
the Shares or of a loan from the broker to the Optionee equal to the Option
Price.

5. Transferability of Option

        This Option may not be transferred, sold, assigned, alienated, pledged
or otherwise encumbered (collectively, a "Transfer"), in whole or in part, by
the Optionee. This Option is exercisable during the Optionee's lifetime only by
the Optionee or, in the event of his Disability or other incapacity, by his
guardian or legal representative.

6. Representations, Warranties and Covenants of Optionee

        The Optionee, by acceptance hereof, hereby: (i) acknowledges that the
Optionee understands that the right to transfer any or all of the Shares will be
restricted; (ii) acknowledges that the Optionee may not transfer the Shares
unless they are registered under the Act, or an exemption from registration is
available; (iii) acknowledges that the certificates representing the Shares will
bear a legend, and that the stock transfer books of the Company will be noted,
to the foregoing effect; (iv) recognizes that the Company does not represent and
has not represented that it will register the Shares under the Act or comply
with any requirements for exemption therefrom, nor does it contemplate any
future registration under or eligibility for exemption from registration under
the Act. As a result, the Optionee acknowledges that the Optionee is prepared to
bear the economic risk of investment in the Shares for an indefinite period of
time.

        The Optionee, by his acceptance hereof, hereby represents, warrants and
covenants that: (a) the Optionee will acquire the Shares for the Optionee's
account for investment and not with a view towards distribution and shall not
sell, hypothecate, transfer or otherwise dispose of the Shares unless such
transaction has been registered under the Act or, in the opinion of counsel for
the Company, an exemption from registration is available; (b) the

                                       3
<PAGE>   12

Optionee has adequate means of providing for the Optionee's current needs and
possible contingencies and has no need for liquidity of the Shares; the
Optionee's overall commitment to investments is not disproportionate to the
Optionee's net worth, and investment in the Shares will not cause such overall
commitment to become excessive; (c) prior to the acceptance hereof, the Optionee
had the opportunity to examine and read all documents, records and books
pertaining to this investment which have been made available for inspection by
the Optionee and by the Optionee's attorney, accountant and other financial
advisors; (d) the Optionee recognizes that such documents do not contain all of
the information that would be contained in a Registration Statement under the
Act with respect to the offer and sale of the Shares and has conducted the
investigation pertaining to the Optionee's purchase of the Shares accordingly;
(e) the Optionee is familiar with the business, management and condition
(financial and other) of the Company and has had the opportunity to ask
questions of, and receive answers from, representatives of the Company
concerning the business, management and condition (financial and other) of the
Company and to obtain any investment decision; (f) the Optionee is knowledgeable
and experienced in financial and business matters, is fully cognizant that the
investment contemplated hereby involves a high degree of risk and is able to
evaluate the merits and risks of an investment in the Shares; (g) all
information which the Optionee has provided herein concerning the Optionee and
the Optionee's financial position is correct and complete as of the date hereof;
and (h) the Optionee has been given no other written representations or
assurances by the Company or any representatives of the Company in connection
with this investment.

7. Rights

        The Optionee shall not, by reason of the granting of this Option, have
or thereby acquire any rights of a stockholder of the Company with respect to
any Shares unless and until this option has been exercised in the manner
contemplated by, and subject to the conditions contained in, Section 3 hereof.
Nothing contained herein shall confer upon the Optionee any right with respect
to the continuation of his employment by the Company or any Affiliated
Corporation or interfere in any way with the right of the Company, subject to
the terms of a written Employment Agreement between the Company and the Optionee
to the contrary, at any time to terminate such employment or

                                       4
<PAGE>   13

to increase or decrease the compensation payable to the Optionee from the rate
in existence on the date hereof.

8. Acceptance by Optionee.

        Acceptance of this Option by the Optionee shall be deemed the agreement
of the Optionee to all of the terms hereof.

        IN WITNESS WHEREOF, the Company has caused this option to be executed by
its officer thereunto duly authorized.

                                       "COMPANY"

                                       RNETHEALTH, INC.

                                       By:
                                          --------------------------------------
                                          Robert Portrie
                                          Chairman of the Board

                                       "OPTIONEE"

                                       Accepted
                                       By:
                                           -------------------------------------
                                           Wendy Borow Johnson

                                       5<PAGE>   1
                                                                    Exhibit 10.2

                          CONSULTING SERVICES AGREEMENT

        This CONSULTING SERVICES AGREEMENT (the "Agreement") is made as of this
9th day of July 1999, between RNETHealth.com, Inc., a Colorado corporation (the
"Company"), and Kevin Wall, an individual residing in Los Angeles, California
(the "Consultant").

        Consultant has been retained by the Company to serve as a consultant and
advisor, on a non-exclusive basis for a period of two (2) years, commencing on
the date hereof, on the following terms and conditions:

1. SERVICES

        Subject to Section 3c, Consultant will provide the following services to
the Company (collectively, hereinafter, the "Services"):

        a. Consulting services and advice pertaining to Internet development,
including but not limited to advice with regard to securing a web-site
development alliance.

        b. Consultant will assist the Company in identifying strategic
opportunities that will extend the Company's e-commerce efforts.

        c. Consultant shall advise the Company concerning the creation of an
Internet presentation for potential Wall Street investors and members of the
healthcare industry. Upon the Company's reasonable request, Consultant shall
assist the Company in presenting a reasonable number of such presentations to
potential investors.

        d. Consultant will use his reasonable best efforts, to arrange
introductions and meetings between representatives of the Company and
individuals and institutions interested in an investment in the Company. In the
event that the introduction by Consultant to potential investors results in an
investment, the Company shall pay to Consultant a fee equal to the "Lehman
Formula" of any cash or equivalent value received by the Company as a direct
result of such introduction.

        e. Consultant has been nominated to serve on the Board of Advisors of
the Company and has accepted such invitation and will serve on the Board of
Advisors as Chairman.

2. Compensation

        The Company agrees to issue and deliver to Consultant, immediately upon
Consultant's execution of this Agreement and Consultant agrees to accept a
Common Stock Purchase Warrant ("Warrant") to purchase One Million Fifteen
Thousand (1,015,000) shares of Common Stock of the Company at $0.15 per share in
exchange for the Services to be rendered under this Agreement. The agreement
evidencing the Warrant is attached hereto as Schedule A. The Company and the
Consultant agree that the issuance of the warrant is a non-recognition event for
income tax purposes. Upon the execution of this Agreement, the Warrant will be
validly issued, fully paid and nonassessable, free and clear of any and all
liens and encumbrances, will be issued in compliance with all applicable federal
and state securities laws, and will be fully earned by Consultant. The Common
Stock, when issued upon exercise of the Warrant, will be fully paid and
nonassessable, free and clear of all liens and encumbrances and will be issued
in compliance with all applicable federal and state securities laws. No person
or entity shall have any preemptive, anti-dilutive or other similar rights to
purchase any equity securities of the

<PAGE>   2

Company that are triggered or created by the issuance of the Warrant or the
issuance of any Common Stock upon its exercise.

3. GENERAL PROVISIONS

        a. Indemnification. In the absence of willful malfeasance on the part of
Consultant, Consultant shall not be subject to any liability to the Company or
to any officer, director, employee, shareholder or other affiliate of the
Company, for any act or omission in the course of or connected with his
providing of the Services hereunder. The Company agrees to defend Consultant in,
and fully indemnify Consultant for any expenses or losses incurred or suffered
with respect to, any claim, action or proceeding brought against Consultant and
to promptly reimburse Consultant for all losses and expenses that may be
suffered or incurred as a result of or arising out of an alleged cause of action
created or incurred, or alleged to have been created or incurred, by reason of
or arising out of his providing of the Services hereunder. All expenses and
other losses incurred or suffered by Consultant in connection with any such
claim, action or proceeding shall be paid by the Company prior to and following
the final disposition thereof within fifteen days after receiving from
Consultant copies of invoices presented to the Company for such expenses and
losses. The Company's defense of Consultant shall be at no expense to
Consultant; provided, however, that if Consultant desires to obtain his own
counsel, the fees and expenses of such counsel shall be borne by Consultant;
provided further, however, that if Consultant shall reasonably conclude that a
conflict of interest exists between the Company and Consultant, the fees and
expenses of counsel to Consultant shall be borne and paid by the Company prior
to and following the final disposition of any such claim, action or proceeding
within fifteen days after receiving from Consultant copies of invoices presented
to the Company for such fees and expenses.

        b. No Litigation. The Company represents and warrants to Consultant that
there are no actions, proceedings, complaints, grievances or investigations
pending or, to the best of the Company's knowledge, threatened against the
Company or any of its subsidiaries, assets or properties.

        c. Independent Contractor. This Agreement creates, and shall be
construed to create, the relationship of contractor and independent contractor
between the Company and Consultant, and nothing herein shall be deemed to
prohibit Consultant from performing services of any nature for any other person
or entity or engaging in any business activity whatsoever, including the
performing of services or the engaging in business activities that compete
directly with the Company. The Company acknowledges and agrees that Consultant
will or may, following the date hereof, continue to work extensively and
actively in investing in, forming, operating and advising companies engaged in a
variety of industries, including industries involving or relating to the
Internet. Accordingly, the Company agrees and acknowledges that nothing
contained in this Agreement shall be deemed, whether express or implied, to (i)
require Consultant to devote any specific times during any working day(s) or
amounts of working hours toward the performance of the Services hereunder or
otherwise, (ii) require Consultant to relocate or otherwise engage in any
traveling outside of Los Angeles County, California in connection with the
performance of the Services hereunder, or otherwise, unless with Consultant's
specific consent thereto. The Company further agrees and acknowledges that
Consultant shall render the Services hereunder without any supervision of the
Company and at such time and place and in such manner as Consultant may
determine in his sole discretion. In no event shall Consultant be deemed to be
an employee, officer or director of the Company, nor shall Consultant at any
time be deemed to be an agent or representative of the Company or have any power
to bind or commit the Company or otherwise act on the Company's behalf.

        d. Expenses. In addition to the compensation to be paid to Consultant as
provided above,
<PAGE>   3

the Company shall pay to and reimburse Consultant for, promptly as billed, all
expenses incurred by Consultant in connection with his rendering of the Services
hereunder.

        e. Publicity. No advice rendered by Consultant in connection with the
Services performed by Consultant pursuant to this Agreement will be quoted by
either party hereto, nor will be referred to in any communication without the
prior written authorization of both parties hereto, except to the extent
required by law (in which case the appropriate party shall so advise the other
in writing prior to such use and shall consult with the other with respect to
the form and timing of disclosure), provided that the foregoing shall not
prohibit appropriate communication or reference with respect to such advice
internally within such parties. Furthermore, except as required by law,
regulation or stock exchange requirements, the Company shall not, and shall
cause its affiliates not to, issue or cause the publication of any press release
or other announcement with respect to Consultant and/or the Services to be
performed under this Agreement without the prior written consent of Consultant.

        f. Third Party Beneficiaries. This Agreement has been and is made solely
for the benefit of the Company, Consultant and their respective successors and
assigns, and no other person shall acquire or have any rights under or by virtue
of this Agreement.

        g. Services Rendered Solely to the Company. Consultant shall render the
Services to the Company solely for the consideration and action of the Company.
In no event shall advice or consultation services of Consultant be binding on
the Company or bind the Company contractually with third parties. Consultant
shall have no authority to act on behalf of, or to bind, the Company, and no
person or entity, except the Company, shall be authorized to act or rely upon
advice of the Consultant. Consultant shall have no authority to authorize,
approve or ratify the taking of, or failure to take, any action by any officer
or employee of the Company. Consultant shall report only to the President or
Chairman of the Company.

        h. Information: Compliance with Laws. The Company shall make available
to Consultant all information concerning its business and operations which
Consultant requests as well as any other information relating to any transaction
prepared by the Company or any of its agents, representatives or other advisors.
All information and material provided by, or on behalf of, the Company to
Consultant will be true and correct in all material respects, will not contain
any untrue statement of a material fact or omit to state any material fact
necessary to make any such information or materials not misleading. Consultant
shall be entitled to rely upon all information supplied to it by the Company or
its agents, representatives or advisors and shall not in any respect be
responsible for the accuracy or completeness of, or have any obligation to
verify the same. The Company shall conduct its business and operations in
compliance with all applicable laws, including federal and state securities
laws.

        i. Termination. This Agreement may be terminated by Consultant upon
advance written notice if any provision hereof is breached by the Company.

        j. Notices. Any notice by one party to the other party concerning this
Agreement shall be given in writing and shall be deemed effectively given upon
personal delivery to the party to be notified or, if sent by facsimile, upon
receipt of confirmation of transmission, if sent on a business day, or three (3)
days after the deposit with the United States Post Office, by registered or
certified mail, or one (1) day after the deposit with an overnight air courier,
in each case postage prepaid and addressed to the party to be notified at the
address indicated for such party below, or at such other address or facsimile
number as such party may designate by ten (10) days' advance written notice to
the other party given in accordance with this paragraph:
<PAGE>   4

        If to the Company:

        RNETHealth.com, Inc.
        1411 Fifth Street, Suite 200
        Santa Monica, California 90401
        Fax: (310) 393-5749

        If to Consultant:

        Kevin Wall
        1670 No. Doheny Dr.
        Los Angeles, California 90069
        Fax: (310) 275-7471

        k. Successor and Assigns. This Agreement shall be binding upon and inure
to the benefit of each of the parties hereto and their respective legal
representatives, successors and permitted assigns. This Agreement shall not be
assigned or assumed by any party hereto without the prior written consent of the
other party hereto.

        1. Attorneys' Fees. If either party institutes any legal action to
enforce his or its rights under or to recover damages for any breach of this
Agreement, the prevailing party in such action shall be entitled to recover from
the other party all costs (including costs of arbitration or mediation, if any)
and all reasonable expenses for attorney's fees and disbursements incurred by
him or it.

        m. Headings. The headings in this Agreement are intended solely for
convenience of reference and shall be given no effect in the construction or
interpretation of this Agreement.

        n. Execution and Counterparts. This Agreement may be executed in
counterparts, each and both of which shall be deemed for all purposes to be one
agreement.

        o. Severability. If one or more provisions of this Agreement is held to
be unenforceable under applicable law, such provision shall be excluded from
this Agreement and the balance of this Agreement shall be interpreted as if such
provision were so excluded and shall be enforceable in accordance with its
terms.

        p. Entire Agreement. This Agreement supersedes any and all agreements,
either oral or written, between the parties hereto with respect to the provision
of Services by Consultant for the Company and contains all the covenants and
agreements between the parties with respect to the rendering of such services in
any manner whatsoever.

        q. Modifications. Any modifications of this Agreement will be effective
only if in writing and signed by both parties.

        r. Choice of Law. This Agreement will be governed by and construed in
accordance with the laws of the State of California.

        s. Dispute Resolution. Any disputes arising under this Agreement will be
resolved by binding arbitration, before a single arbitrator, to take place in
the County of Los Angeles under the rules

<PAGE>   5

of the American Arbitration Association.

AGREED TO AND ACCEPTED oh the date first written above.

RNETHEALTH.COM, INC.                        CONSULTANT

By:  /s/ WILLIAM MOSES                      By: /s/ Kevin Wall
   --------------------------------            ---------------------------------
         William Moses                              Kevin Wall
         President

<PAGE>   6

                                                                      Schedule A

THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR APPLICABLE
STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE
OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT OR THE
COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT UNDER SAID ACT AND
APPLICABLE STATE SECURITIES LAWS AN EXEMPTION THEREFROM, OR AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO RNETHEALTH.COM, INC. THAT SUCH REGISTRATION
IS NOT REQUIRED.

                                Right to Purchase 1,015,000 Shares of Common
                                Stock of RNETHealth.com, Inc. (subject to
                                adjustment as provided herein)

                          COMMON STOCK PURCHASE WARRANT

No. 1                                                               July 9, 1999

        RNETHealth.com, Inc., a corporation organized under the laws of the
State of Colorado (the "Company"), hereby certifies that, for value
received, Kevin Wall (the "Warrantholder"), is entitled, subject to the terms
set forth below, to purchase from the Company, upon execution of the Consulting
Services Agreement, at any time or from time to time before 5:00 p.m., New York
time, on July 9, 2001 (the "Expiration Date"), up to 1,015,000 fully paid and
nonassessable shares of Common Stock (as hereinafter defined), $.01 par value
per share, of the Company, at a purchase price of $.15 per share (such purchase
price per share as adjusted from time to time as herein provided is referred to
herein as the "Purchase Price"). The number and character of such shares of
Common Stock and the Purchase Price are subject to adjustment as provided
herein.

        As used herein the following terms, unless the context otherwise
requires, have the following respective meanings:

        (a) The term "Company" shall include RNETHealth.com, Inc. and any
corporation, which shall succeed or assume the obligations of RNETHealth.com,
Inc. hereunder.

        (b) The term "Common Stock" includes (a) the Company's Common Stock,
$.01 par value per share, as authorized on the date of the Agreement, (b) any
other capital stock of any class or classes (however designated) of the Company,
authorized on or after such date, the holders of which shall have the right,
without limitation as to amount, either to all or to a share of the balance of
current dividends and liquidating dividends after the payment of dividends and
distributions on any shares entitled to preference, and the holders of which
shall ordinarily, in the absence of contingencies, be entitled to vote for the
election of a majority of directors of the Company (even if the right so to vote
has been suspended by the happening of such a contingency) and (c) any other
securities into which or for which any of the securities described in (a) or (b)
may be converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise.

                                       -1-
<PAGE>   7

        (c) The term "Other Securities" refers to any stock (other than Common
Stock) and other securities of the Company or any other person (corporate or
otherwise) which the holder of the warrant at any time shall be entitled to
receive, or shall have received, on the exercise of the Warrant, in lieu of or
in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 3,4 or 5 or otherwise.

        1.     Exercise of Warrant.

               1.1. Number of Shares Issuable upon Exercise. From and after the
date hereof through and including the Expiration Date, the holder hereof shall
be entitled to receive, upon exercise of this Warrant in whole in accordance
with the terms of subsection 1.2 or upon exercise of this warrant in part in
accordance with subsection 1.3, or upon exercise of the Cashless Exercise Right
(as defined herein) pursuant to Section 1.4 the number of shares of Common Stock
of the Company identified on Page 1 hereof, subject to adjustment pursuant to
Section 4.

               1.2. Full Exercise. This Warrant may be exercised in full by the
holder hereof by surrender of this Warrant, with the form of subscription
attached as Exhibit A hereto (the "Subscription Form") duly executed by such
holder, to the Company at its principal office or at the office of its warrant
agent (as provided in Section 10), accompanied by payment, in cash or by
certified or official bank check payable to the order of the Company, in the
amount obtained by multiplying the number of shares of Common Stock for which
this Warrant is then exercisable by the Purchase Price (as hereinafter defined)
then in effect.

               1.3. Partial Exercise. This Warrant may be exercised in part (but
not for a fractional share) by surrender of this Warrant in the manner and at
the place provided in subsection 1.2 except that the amount payable by the
holder on such partial exercise shall be the amount obtained by multiplying (a)
the number of shares of Common Stock designated by the holder in the
Subscription Form by (b) the Purchase Price then in effect. On any such partial
exercise, the Company, at its expense, will forthwith issue and deliver to or
upon the order of the holder hereof a new Warrant of like tenor, in the name of
the holder hereof or as such holder (upon payment by such holder of any
applicable transfer taxes), may request, the number of shares of Common Stock
for which such warrant may still be exercised.

               1.4. Cashless Exercise. This Warrant may also be exercised in
whole or in part by exercise of the Warrantholder's Cashless Exercise Right. The
Warrantholder shall have the right to require the Company to reduce the number
of shares of Common Stock to be received by the Warrantholder in lieu of paying
the Purchase Price in cash (the "Cashless Exercise Right"). If the Cashless
Exercise Right is exercised, the holder shall not be obligated to pay the
Purchase Price in cash and the Company shall deliver to such holder the number
of duly authorized, validly issues, fully paid and non-assessable shares of
Common Stock determined by Section 1.2, in the case of an exercise in whole, or

                                       -2-
<PAGE>   8

1.3, in the case of an exercise in part, reduced by that number of shares of
Common Stock equal to the quotient obtained by dividing (i) the product of the
Purchase Price then in effect multiplied the number of shares which the
Warrantholder has elected to have issued pursuant to this Warrant by (ii) the
Fair Market Value of one share of Common Stock.

               1.5. Fair Market Value. Fair Market Value of a share of Common
Stock as of a particular date (the "Determination Date") shall mean the Fair
Market value of a share of the Company's Common Stock. Fair Market Value of a
share of Common Stock as of a Determination Date shall mean:

                      (a) If the Company's Common Stock is traded on an exchange
or is quoted on the National Association of Securities Dealers, Inc. Automated
Quotation ("NASDAQ") National Market System or the NASDAQ SmallCap Market, then
the closing or last sale price, respectively, reported for the last business day
immediately preceding the Determination Date.

                      (b) If the Company's Common Stock is not traded on an
exchange or on the NASDAQ National Market System or the NASDAQ SmallCap Market
but is traded in the over-the-counter market, then the mean of the closing bid
and asked prices reported for the last business day immediately preceding the
Determination Date.

                      (c) Except as provided in clause (d) below, if the
Company's Common Stock is not publicly traded, then as the Holder and the
Company agree or in the absence of agreement by arbitration in accordance with
the rules then standing of the American Arbitration Association, before a single
arbitrator to be chosen from a panel of persons qualified by education and
training to pass on the matter to be decided.

                      (d) If the Determination Date is the date of a
liquidation, dissolution or winding up, or any event deemed to be a liquidation,
dissolution or winding up pursuant to the Company's charter, then all amounts to
be payable per share to holders of the Common Stock pursuant to the charter in
the event of such liquidation, dissolution or winding up, plus all other amounts
to be payable per share in respect of the Common Stock in liquidation under the
charter, assuming for the purposes of this clause (d) that all of the shares of
Common Stock then issuable upon exercise of all of the Warrants are outstanding
at the Determination Date.

               1.6. Company Acknowledgment. The Company will, at the time of the
exercise of the Warrant, upon the request of the holder hereof acknowledge in
writing its continuing obligation to afford to such holder any rights to which
such holder shall continue to be entitled after such exercise in accordance with
the provisions of this Warrant. If the holder shall fail to make any such
request, such failure shall not affect the continuing obligation of the Company
to afford to such holder any such rights.

               1.7. Trustee for Warrant Holders. In the event that a bank or
trust company shall have been appointed as trustee for the holders of the
Warrants pursuant to Subsection 3.1, such bank or trust company shall have all
the powers

                                       -3-

<PAGE>   9

and duties of a warrant agent appointed pursuant to Section 10 and shall accept,
in its own name for the account of the Company or such successor person as may
be entitled thereto, all amounts otherwise payable to the Company or such
successor, as the case may be, on exercise of this Warrant pursuant to this
Section 1.

        2. Delivery of Stock Certificates, etc. on Exercise. The Company agrees
that the shares of Common Stock purchased upon exercise of this Warrant shall be
deemed to be issued to the holder hereof as the record owner of such shares as
of the close of business on the date on which this Warrant shall have been
surrendered and payment made for such shares as aforesaid. As soon as
practicable after the exercise of this Warrant in full or in part, and in any
event within 10 days thereafter, the Company at its expense (including the
payment by it of any applicable issue taxes) will cause to be issued in the name
of and delivered to the holder hereof, or as such holder (upon payment by such
holder of any applicable transfer taxes) may direct, a certificate or
certificates for the number of duly and validly issued, fully paid and
nonassessable shares of Common Stock (or Other Securities) to which such holder
shall be entitled on such exercise, plus, in lieu of any fractional share to
which such holder would otherwise be entitled, cash equal to such fraction
multiplied by the then Fair Market Value of one full share, together with any
other stock or other securities and property (including cash, where applicable)
to which such holder is entitled upon such exercise pursuant to Section 1 or
otherwise.

        3. Adjustment for Reorganization, Consolidation, Merger, etc.

               3.1. Reorganization, Consolidation, Merger, etc. In case at any
time or from time to time, the Company shall (a) effect a reorganization, (b)
consolidate with or merge into any other person, or (c) transfer all or
substantially all of its properties or assets to any other person under any plan
or arrangement contemplating the dissolution of the Company, then, in each such
case, as a condition to the consummation of such a transaction, proper and
adequate provision shall be made by the Company whereby the holder of this
Warrant, on the exercise hereof as provided in Section 1 at any time after the
consummation of such reorganization, consolidation or merger or the effective
date of such dissolution, as the case may be, shall receive, in lieu of the
Common Stock (or Other Securities) issuable on such exercise prior to such
consummation or such effective date, the stock and other securities and property
(including cash) to which such holder would have been entitled upon such
consummation or in connection with such dissolution, as the case may be, if such
holder had so exercised this warrant, immediately prior thereto, all subject to
further adjustment thereafter as provided in Section 5.

               3.2. Dissolution. In the event of any dissolution of the Company
following the transfer of all or substantially all of its properties or assets,
the Company, prior to such dissolution, shall at its expense deliver or cause to
be delivered the stock and other securities and property (including cash, where
applicable) receivable by the holders of the Warrants, if exercised, after the
effective date of such dissolution pursuant to this Section 3 to a bank or trust
company having its principal office in Los Angeles, CA, as trustee for the
holder or holders of the Warrants.

                                       -4-
<PAGE>   10

               3.3. Continuation of Terms. Upon any reorganization,
consolidation, merger or transfer (and any dissolution following any transfer)
referred to in this Section 3, this Warrant shall continue in full force and
effect and the terms hereof shall be applicable to the shares of stock and other
securities and property receivable on the exercise of this Warrant after the
consummation of such reorganization, consolidation or merger or the effective
date of dissolution following any such transfer, as the case may be, and shall
be binding upon the issuer of any such stock or other securities, including, in
the case of any such transfer, the person acquiring all or substantially all of
the properties or assets of the Company, whether or not such person shall have
expressly assumed the terms of this Warrant as provided in Section 5.

        4. Extraordinary Events Regarding Common Stock. In the event that the
company shall (a) issue additional shares of the Common Stock as a dividend or
other distribution on outstanding Common Stock, (b) subdivide its outstanding
shares of Common Stock, or (c) combine its outstanding shares of the Common
Stock into a smaller number of shares of the Common Stock, then, in each such
event, the Purchase Price shall, simultaneously with the happening of such
event, be adjusted by multiplying the then Purchase Price by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the Purchase Price then in effect. The
Purchase Price, as so adjusted, shall be readjusted in the same manner upon the
happening of any successive event or events described herein in this Section 4.
The number of shares of Common Stock that the holder of this Warrant shall
thereafter, on the exercise hereof as provided in Section 1, be entitled to
receive shall be increased to a number determined by multiplying the number of
shares of Common Stock that would otherwise (but for the provisions of this
Section 4) be issuable on such exercise by a fraction of which (a) the numerator
is the Purchase Price that would otherwise (but for the provisions of this
Section 4) be in effect, and (b) the denominator is the Purchase Price in effect
on the date of such exercise.

        5. Chief Financial Officers Certificate as to Adjustments. In each case
of any adjustment or readjustment in the shares of Common Stock (or other
Securities) issuable on the exercise of the Warrants, the Company at its expense
will promptly cause its Chief Financial Officer to compute such adjustment or
readjustment in accordance with the terms of the Warrant and prepare a
certificate setting forth such adjustment or readjustment and showing in detail
the facts upon which such adjustment or readjustment is based, including a
statement of (a) the consideration received or receivable by the Company for any
additional shares of Common Stock (or Other Securities) issued or sold or deemed
to have been issued or sold, (b) the number of shares of Common Stock (or Other
Securities) outstanding or deemed to be outstanding, and (c) the Purchase Price
and the number of shares of Common Stock to be received upon exercise of this
Warrant, in effect immediately prior to such adjustment or readjustment and as
adjusted or readjusted as provided in this Warrant. The Company will forthwith
mail a copy of each such certificate to the holder of the Warrant and any
Warrant agent of the Company (appointed pursuant to Section 10 hereof).

                                       -5-

<PAGE>   11

        6. Reservation of Stock. etc. Issuable on Exercise of Warrant; Financial
Statements. The Company will at all times reserve and keep available, solely for
issuance and delivery on the exercise of the Warrants, all shares of Common
Stock (or Other Securities) from time to time issuable on the exercise of the
Warrant. This Warrant entitles the holder hereof to receive copies of all
financial and other information distributed or required to be distributed to the
holders of the Company's Common Stock.

        7. Registration Rights.

               7.1 Definitions. As used in this Section, the following terms
shall have the following respective meanings:

               "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended from time to time.

               "Form S-3" shall mean such form under the Securities Act as in
effect on the date hereof or any successor registration form under the
Securities Act subsequently adopted by the SEC which permits inclusion or
incorporation of substantial information by reference to other documents filed
by the Company with the SEC.

               "Form S-8" shall mean such form under the Securities Act as in
effect on the date hereof or any successor registration form under the
Securities Act subsequently adopted by the SEC relating to the issuance of
securities to officers, directors, employees, consultants, advisors and other
persons providing services to the Company, generally pursuant to an employee
benefit plan or written agreement.

               "Other Holders" shall have the meaning set forth in Section
7.3(a).

               "Prospectus" shall mean the prospectus included in any
Registration Statement, as amended or supplemented by any prospectus supplement
with respect to the terms of the offering of any portion of the Registrable
Securities covered by the Registration Statement and by all other amendments and
supplements to the prospectus, including post-effective amendments and all
material incorporated by reference in such Prospectus.

               "Register," "registered" and registration" shall mean and refer
to a registration effected by preparing and filing a Registration Statement and
taking all other actions that are necessary or appropriate in connection
therewith, and the declaration or ordering of effectiveness of such Registration
Statement by the SEC.

               "Registration Expenses" shall have the meaning set forth in
Section 7.5.

               "Registrable Securities" shall mean the Common Stock or Other
Securities issued upon exercise of this Warrant, provided that such term shall
not include any such shares of Common Stock or Other Securities sold to the

                                       -6-

<PAGE>   12
public by Warrantholder pursuant to a Registration Statement or to Rule 144
under the Securities Act.

               "Registration Statement" shall mean any registration statement of
the Company in compliance with the Securities Act, including a registration
statement on Form S-8, that covers Registrable Securities pursuant to the
provisions of this Agreement, including, without limitation, the Prospectus, all
amendments and supplements to such Registration Statement, including all post
effective amendments, all exhibits and all material incorporated by reference in
such Registration Statement.

               "Securities Act" shall mean the Securities Act of 1933, as
amended from time to time.

               "SEC" shall mean the Securities and Exchange Commission.

               "Underwritten offering" shall mean a registration in which
securities of the Company are sold to an underwriter or through an underwriter
as agent for reoffering to the public.

               7.2 Form S-3 and Form S-8 Registration.

                      a. The Warrantholder shall, from time to time, subject to
the provisions of this Section, be entitled to request that the Company effect a
registration of all or such portion of the Warrantholder's Registrable
Securities on Form S-3 or Form S-8 as shall be specified in such request.

                      b. As soon as practicable after receipt of any written
request pursuant to Section 7.2(a), the Company shall effect such registration
as would permit or facilitate the sale and distribution of all or such portion
of the Warrantholder's Registrable Securities as are specified in such request,
provided that the Company shall not be obligated to effect any such registration
pursuant to this Section, pursuant to Form S-3 if the Warrantholder proposes to
sell Registrable Securities at an aggregate price to the public of less than
$200,000 or if the Company shall furnish to the Warrantholder a certificate
signed by the President or Chief Executive officer stating that in the good
faith judgment of the Board of Directors, it would be seriously detrimental to
the Company and its shareholders for such Form S-3 or Form S-8 Registration to
be effected at such time, in which event the Company shall have the right to
defer the filing of the Form S-3 or Form S-8 Registration Statement for a period
of not more than sixty (60) days after receipt of the request described in
Section 7.2(a).

                                      -7-

<PAGE>   13

                      c. Subject to Section 7.2 (b), the Company shall file a
Form S-3 or Form S-8 Registration Statement, as requested by the Warrantholder,
covering the Registrable Securities as soon as practicable after receipt of the
request by the Warrantholder.

                      d. At all times that the Company is subject to the
reporting requirements of the Exchange Act, the Company shall use its best
efforts to make registrations on Form S-3 and Form S-8 available for the sale of
Registrable Securities.

               7.3. Company Registration. If the Company shall determine to
register any shares of its capital stock of the same series and class as any of
the Registrable Securities (or securities convertible into or exchangeable or
exercisable for shares of such series and class) for its own account or for the
account of any shareholder, the Warrantholder shall be entitled to include
Registrable Securities in such registration (and related underwritten offering,
if any) on the following terms and conditions:

                      a. The Company shall promptly give written notice of such
determination to the Warrantholder and each holder of securities of the Company
that has registration rights triggered by such registration (the "Other
Holders"), and the Warrantholder and each Other Holder shall have the right to
request, by written notice given to the Company within thirty (30) days of the
receipt by the Warrantholder and the Other Holders of such notice, that a
specific number of Registrable Securities and eligible shares held thereby be
included in such Registration Statement;

                      b. If the Registration Statement relates to an
underwritten offering, the notice called for by Section 7.3 (a) shall specify
the name of the managing underwriter for such offering and the number of
securities to be registered for the account of the Company and for the account
of any of the other shareholders of the Company;

                      c. If the Registration Statement relates to an
underwritten offering, the Warrantholder and each Other Holder to be included
therein, must sell such person's Registrable Securities and shares on the same
basis provided in the underwriting arrangements approved by the Company and
complete and execute all questionnaires, powers of attorney, indemnities,
hold-back agreements, underwriting agreements and other documents required under
the terms of such underwriting arrangements or by the SEC;

                      d. If the managing underwriter for the underwritten
offering under the Registration Statement to be filed by the Company determines
that inclusion of all or any portion of the Registrable Securities and shares
held by the Other Holders in such offering would adversely affect the ability of
the underwriter for such offering to sell all of the securities requested to be
included for sale in such offering, the number of shares that may be included in
such registration in such offering (the "Maximum Number") shall be allocated as
follows: (a) first, the Company shall be permitted to include all shares of
capital stock to be registered thereby and (b) second, to the extent the number
of shares sought to be sold under clause (a) is less than the Maximum Number,

                                       -8-

<PAGE>   14

then such number of Registrable Securities and shares held by the Other Holders,
pro rata in proportion to the number sought to be registered by the
Warrantholder and each Other Holder relative to the aggregate number sought to
be registered by the Warrantholder and all Other Holders, which, in the
aggregate and when added to the number of shares to be registered under clause
(a), equals the maximum Number;

                      e. The Warrantholder shall have the right to withdraw his
Registrable Securities from the Registration Statement at any time prior to the
effective date thereof, but if the same relates to an underwritten offering, he
may only do so during the time period and on terms deemed appropriate by the
underwriters for such underwritten offering; and

                      f. The Company shall have the right to terminate or
withdraw any registration initiated by it under this Section 7.3 prior to the
effective date of such registration, whether or not the Warrantholder has
elected to include such securities in such registration.

               7.4 Registration Procedures. In connection with the Company's
registration obligations pursuant to Sections 7.2 or 7.3 hereof, the Company
will use its best efforts to effect such registration to permit the sale of the
Registrable Securities covered thereby in accordance with the intended method or
methods of disposition thereof, and pursuant thereto the Company will as
expeditiously as possible:

                      a. prepare and file with the SEC a Registration Statement
with respect to such Registrable Securities and use its best efforts to cause
such Registration Statement to become effective, and, upon the request of the
Warrantholder, keep such registration statement effective for up to ninety (90)
days, provided that, before filing any Registration Statement or Prospectus or
any amendments or supplements thereto, the Company will furnish to the
Warrantholder and his counsel, and the underwriter, if any, and their counsel,
copies of all such documents proposed to be filed at least ten (10) days prior
thereto, and, with respect to any Registration Statement prepared to be filed by
the Company, the Company will not file any such Registration Statement or
amendment thereto or any Prospectus or any supplement thereto to which the
Warrantholder shall object within such ten (10) day period, provided, further,
that the Company will not name or otherwise provide any information with respect
to the Warrantholder in any Registration Statement or Prospectus without the
consent of such person, unless required to do so by the Securities Act and the
rules and regulations thereunder;

                      b. prepare and file with the SEC such amendments,
post-effective amendments and supplements to the Registration Statement and the
Prospectus as may be necessary to comply with the provisions of the Securities
Act and the rules and regulations thereunder with respect to the disposition of
all securities covered by such Registration Statement;

                      c. promptly notify the Warrantholder (i) when the
Prospectus or any Prospectus supplement or post-effective amendment has been
filed, and, with respect to the Registration Statement or any post-effective

                                       -9-

<PAGE>   15

amendment, when the same has become effective, (ii) of any request by the SEC
for amendments or supplements to the Registration Statement or the Prospectus or
for additional information, (iii) of the issuance by the SEC of any stop order
suspending the effectiveness of the Registration Statement or the initiation of
any proceedings for that purpose, (iv) if at any time the representations and
warranties of the Company contemplated by Section 7.4 (k) cease to be true and
correct, (v) of the receipt by the Company of any notification with respect to
the suspension of the qualification of the Registrable Securities for sale in
any jurisdiction or the initiation or threatening of any proceeding for such
purpose and (vi) of the happening of any event which makes any statement made in
the Registration Statement, the Prospectus or any document incorporated therein
by reference untrue or which requires the making of any changes in the
Registration Statement, the Prospectus or any document incorporated therein by
reference in order to make the statements therein not misleading;

                      d. make every reasonable effort to obtain the withdrawal
of any order suspending the effectiveness of the Registration Statement at the
earliest possible moment;

                      e. if requested by the Warrantholder, immediately
incorporate in a Prospectus supplement or post-effective amendment such
information as the Warrantholder requests should be included therein relating to
the sale of the Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being sold, the
purchase price being paid therefor and any other terms of the distribution of
the Registrable Securities to be sold in such offering; and make all required
filings of such Prospectus supplement or post-effective amendment as promptly as
practicable after being notified of the matters to be incorporated in such
Prospectus supplement or post-effective amendment;

                      f. furnish to the Warrantholder, without charge, at least
one signed copy of the Registration Statement and any post-effective amendment
thereto, including financial statements and schedules, all documents
incorporated therein by reference and all exhibits (including those incorporated
by reference);

                      g. deliver to the Warrantholder, without charge, such
reasonable number of conformed copies of the Registration Statement (and any
post-effective amendment thereto) and such number of copies of the Prospectus
(including each preliminary prospectus) and any amendment or supplement thereto
(and any documents incorporated by reference therein) as the Warrantholder may
reasonably request, all in full conformity with the Securities Act; the Company
consents to the use of the Prospectus and any amendment or supplement thereto by
Warrantholder in connection with the offer and sale of the Registrable
Securities covered by the Prospectus or any amendment or supplement thereto;

                      h. prior to any offering of Registrable Securities covered
by a Registration Statement, register or qualify or cooperate with the
Warrantholder in connection with the registration or qualification of such
securities for offer and sale under the securities or blue sky laws of such
jurisdictions as the Warrantholder reasonably requests, and use its best efforts

                                      -10-

<PAGE>   16

to keep each such registration or qualification effective, including through new
filings, or amendments or renewals, during the period such Registration
Statement is required to be kept effective pursuant to the terms of this
Warrant; and do any and all other acts or things necessary or advisable to
enable the disposition in all such jurisdictions reasonably requested by the
Warrantholder covered by such Registration Statement, provided that under no
circumstances shall the Company be required in connection therewith or as a
condition thereof to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions;

                      i. cooperate with the Warrantholder and the managing
underwriter or underwriters to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be sold, free of any and all
restrictive legends, such certificates to be in such denominations and
registered in such names as the managing underwriter or underwriters, if any, or
the Warrantholder may request;

                      j. upon the occurrence of any event contemplated by
section 7.4 (c)(vi), prepare a supplement or post-effective amendment to the
Registration Statement or the Prospectus or any document incorporated therein by
reference or file any other required document so that, as thereafter delivered
to the purchasers of the Registrable Securities, the Prospectus will not contain
an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein not misleading;

                      k. (i) make such representations and warranties to the
Warrantholder as are customarily made by issuers to underwriters in underwritten
public offerings; (ii) obtain opinions of counsel to the Company and updates
thereof, addressed to the Warrantholder and covering such matters as are
customarily the subject of opinions of issuer's counsel provided to underwriters
in underwritten public offerings; (iii) obtain "cold comfort" letters and
updates thereof from the Company's independent certified public accountants
addressed to the Warrantholder, such letters to be in customary form and
covering matters of the type customarily requested in "cold comfort" letters by
underwriters in connection with underwritten public offerings; and (iv) deliver
such documents and certificates as may be requested by the Warrantholder to
evidence compliance with clause (i) above and with any customary conditions
contained in the underwriting agreement or other agreement entered into by the
Company with the Warrantholder (the above shall be done at each closing under
such underwriting or similar agreement or as and to the extent required
thereunder);

                      1. make generally available to the Warrantholder earnings
statements satisfying the provisions of Section 11(a) of the Securities Act, no
later than sixty (60) days after the end of any twelve (12) month period (or
ninety (90) days, if such period is a fiscal year) commencing at the end of any
fiscal quarter in which Registrable Securities are sold to underwriters in a
firm or best efforts underwritten offering, or, if not sold to underwriters in
such an offering, beginning with the first month of the Company's first fiscal
quarter commencing after the effective date of the Registration Statement, which
statements shall cover said twelve (12) month period;

                                      -11-

<PAGE>   17

                      m. provide and cause to be maintained a transfer agent and
registrar for all Registrable Securities covered by each Registration Statement
from and after a date not later than the effective date of such Registration
Statement;

                      n. use its best efforts to cause all Registrable
Securities covered by each Registration Statement to be listed, subject to
notice of issuance, prior to the date of the first sale of such Registrable
Securities pursuant to such Registration Statement, on each securities exchange
on which the Common Stock issued by the Company is then listed, and admitted to
trading on the Nasdaq Stock Market or any other similar such market, if the
Common Stock is then admitted to trading thereon; and

                      o. enter into such agreements (including underwriting
agreements in customary form containing, among other things, reasonable and
customary indemnities) and take such other actions as the Warrantholder shall
reasonably request in order to expedite or facilitate the disposition of such
Registrable Securities.

        The Warrantholder agrees that, upon receipt of any notice from the
Company of the happening of any event of the kind described in Section
7.4(c)(vi) hereof, the Warrantholder will forthwith discontinue disposition of
Registrable Securities under the Prospectus related to the applicable
Registration Statement until his receipt of the copies of the supplemented or
amended Prospectus contemplated by Section 7.4(j) hereof, or until he is advised
in writing by the Company that the use of the Prospectus may be resumed. It
shall be a condition precedent to the obligations of the Company to take any
action pursuant to this Section with respect to the Registrable Securities of
the Warrantholder that he shall furnish to the Company such information
regarding himself and the Registrable Securities held thereby as shall be
required by the Securities Act to effect the registration of the Registrable
Securities.

               7.5 Registration Expenses. All expenses incident to any
registration to be effected hereunder and incident to the Company's performance
of or compliance with this warrant, including without limitation all
registration and filing fees, fees and expenses of compliance with securities or
blue sky laws, printing expenses, messenger and delivery expenses, National
Association of Securities Dealers, Inc., stock exchange and qualification fees,
fees and disbursements of the Company's counsel and of independent certified
public accountants of the Company (including the expenses of any special audit
required by or incident to such performance), the fees of counsel representing
the Warrantholder in such offering, expenses of the underwriters that are
customarily requested in similar circumstances by such underwriters (excluding
discounts, commissions or fees of underwriters, selling brokers, dealer managers
or similar securities industry professionals relating to the distribution of the
Registrable Securities), all such expenses being herein called "Registration
Expenses," will be borne by the Company. The Company will also pay its internal
expenses, the expense of any annual audit and the fees and expenses of any
person retained by the Company.

               7.6 Indemnification.

                                      -12-

<PAGE>   18

                      a. Indemnification by the Company. The Company agrees to
indemnify and hold harmless the Warrantholder, and if this warrant should be
transferred to an entity, as applicable, the Warrantholder's officers,
directors, trustees, partners, managers, shareholders, members, employees,
attorneys and each person who controls such Warrantholder (within the meaning of
Section 15 of the Securities Act) from and against any and all losses, claims,
damages and liabilities (including any investigation, legal or other expenses
reasonably incurred in connection with, and any amount paid in settlement of,
any action, suit or proceeding or any claim asserted) to which such
Warrantholder may become subject under the Securities Act, the Exchange Act or
other federal or state statutory law or regulation, at common law or otherwise,
insofar as such losses, claims, damages or liabilities arise out of or are based
upon any untrue statement or alleged untrue statement of a material fact
contained in any Registration Statement, Prospectus or preliminary prospectus or
any amendment or supplement thereto, the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the
statements therein not misleading and any violation or alleged violation by the
Company of the Securities Act, the Exchange Act or any state securities or blue
sky laws in connection with the Registration Statement, Prospectus or
preliminary prospectus or any amendment or supplement thereto, provided that the
Company will not be liable to the Warrantholder to the extent that such loss,
claim, damage or liability arises from or is based upon any untrue statement or
omission based upon written information furnished to the Company by the
Warrantholder.

                      b. Indemnification by Warrantholder. The Warrantholder, to
the extent his Registrable Securities are sold under a Prospectus which is a
part of a Registration Statement, agrees to indemnify and hold harmless the
Company, its directors and each officer who signed such Registration Statement
and each person who controls the Company (within the meaning of Section 15 of
the Securities Act), and each other Holder whose securities are sold under the
Prospectus which is a part of such Registration Statement (and such Other
Holder's officers, directors and employees and each person who controls such
holder within the meaning of Section 15 of the Securities Act), under the same
circumstances as the foregoing indemnity from the Company to the Warrantholder
to the extent that such losses, claims, damages, liabilities or actions arise
out of or are based upon any untrue statement of a material fact or omission of
a material fact that was made in the Prospectus, the Registration Statement, or
any amendment or supplement thereto, in reliance upon and in conformity with
information relating to the Warrantholder furnished in writing to the Company by
the Warrantholder expressly for use therein, provided that in no event shall the
aggregate liability of the Warrantholder exceed the amount of the net proceeds
received by the Warrantholder upon the sale of the Registrable Securities giving
rise to such indemnification obligation. The Company and the Warrantholder shall
be entitled to receive indemnities from underwriters, selling brokers, dealer
managers and similar securities industry professionals participating in the
distribution, to the same extent as customarily furnished by such persons in
similar circumstances.

                      c. Conduct of Indemnification Proceedings. Any person
entitled to indemnification hereunder will (i) give prompt notice to the

                                      -13-

<PAGE>   19

indemnifying party of any claim with respect to which it seeks indemnification
and (ii) permit such indemnifying party to assume the defense of such claim with
counsel reasonably satisfactory to the indemnified party, provided, however,
that any person entitled to indemnification hereunder shall have the right to
employ separate counsel and to participate in the defense of such claim, but the
fees and expenses of such counsel shall be at the expense of such person and not
of the indemnifying party unless (A) the indemnifying party has agreed to pay
such fees or expenses, (B) the indemnifying party shall have failed to assume
the defense of such claim and employ counsel reasonably satisfactory to such
person or (C) in the reasonable judgment of such person and the indemnifying
party, based upon advice of their respective counsel, a conflict of interest may
exist between such person and the indemnifying party with respect to such claims
(in which case, if the person notifies the indemnifying party in writing that
such person elects to employ separate counsel at the expense of the indemnifying
party, the indemnifying party shall not have the right to assume the defense of
such claim on behalf of such person). If the indemnifying party does not assume
such defense, the indemnifying party will not be subject to any liability for
any settlement made without its consent (but such consent will not be
unreasonably withheld). No indemnified party will be required to consent to
entry of any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by all claimants or plaintiffs to such
indemnified party of a release from all liability in respect to such claim or
litigation. Any indemnifying party who is not entitled to, or elects not to,
assume the defense of a claim will not be obligated to pay the fees and expenses
of more than one counsel for all parties indemnified by such indemnifying party
with respect to such claim. As used in this Section 7.6(c), the terms
"indemnifying party", "indemnified party" and other terms of similar import are
intended to include only the Company (and its officers, directors and control
persons as set forth above) on the one hand, and the Warrantholder (and, if
applicable, its officers, directors, trustees, partners, managers, shareholders,
members, employees, attorneys and control persons as set forth above) on the
other hand, as applicable.

                      d. Contribution. If for any reason the foregoing indemnity
is unavailable, then the indemnifying party shall contribute to the amount paid
or payable by the indemnified party as a result of such losses, claims, damages,
liabilities or expenses (i) in such proportion as is appropriate to reflect the
relative benefits received by the indemnifying party on the one hand and the
indemnified party on the other, or (ii) if the allocation provided by clause (i)
above is not permitted by applicable law or provides a lesser sum to the
indemnified party than the amount hereinafter calculated, in such proportion as
is appropriate to reflect not only the relative benefits received by the
indemnifying party on the one hand and the indemnified party on the other but
also the relative fault of the indemnifying party and the indemnified party as
well as any other relevant equitable considerations. Notwithstanding the
foregoing, the Warrantholder shall not be required to contribute any amount in
excess of the amount the Warrantholder would have been required to pay to an
indemnified party if the indemnity under Section 7.6(b) hereof was available. No
person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any person
who was not guilty of such fraudulent misrepresentation. The obligation of any

                                      -14-

<PAGE>   20

person to contribute pursuant to this section 7.6(d) shall be several and not
joint.

                      e. Timing of Payments. An indemnifying party shall make
payments of all amounts required to be made pursuant to the foregoing provisions
of this Section to or for the account of the indemnified party from time to time
promptly upon receipt of bills or invoices relating thereto or when otherwise
due or payable.

                      f. Survival. The indemnity and contribution agreements
contained in this Section shall remain in full force and effect regardless of
any investigation made by or on behalf of the Warrantholder and, if applicable,
its officers, directors, trustees, partners, managers, attorneys, agents or any
person, if any, who controls the Warrantholder as aforesaid, and shall survive
the transfer of such Registrable Securities by the Warrantholder.

               7.7 Preparation: Reasonable Investigation. In connection with the
preparation and filing of a Registration Statement pursuant to the terms of this
Warrant:

                      a. the Company shall, with respect to a Registration
Statement filed pursuant to this Section 7, give the Warrantholder if
Registrable Securities are so registered, his underwriter(s), if any, and his
counsel and accountants the opportunity to participate in the preparation of
such Registration Statement (other than reports and proxy statements
incorporated therein by reference and lawfully and properly filed with the SEC)
and each Prospectus included therein or filed with the SEC, and each amendment
thereof or supplement thereto; and

                      b. the Company shall give the Warrantholder if Registrable
Securities are so registered, his underwriter(s), if any, and his counsel and
accountants such reasonable access to its books and records and such
opportunities to discuss the business of the Company with its officers and the
independent public accountants who have certified its financial statements as
shall be necessary, in the opinion of the Warrantholder or such underwriter(s),
to conduct a reasonable investigation within the meaning of Section 11(b)(3) of
the Securities Act.

               7.8 Rule 144. The Company covenants that it will file, on a
timely basis, the reports required to be filed by it under the Securities Act
and the Exchange Act and the rules and regulations adopted by the SEC
thereunder, and it will take such further action as the Warrantholder may
reasonably request (including, without limitation, compliance with the current
public information requirements of Rule 144 (c) and Rule 144A under the
Securities Act), all to the extent required from time to time to enable such
holder to sell Registrable Securities without registration under the Securities
Act within the limitation of the conditions provided by Rule 144 under the
Securities Act, as such Rule may be amended from time to time, Rule 144A under
the Securities Act, as such Rule may be amended from time to time, or any
similar rule or regulation hereafter adopted by the SEC. Upon the request of the
Warrantholder, the Company will deliver to him a written statement verifying
that it has complied with such

                                      -15-

<PAGE>   21
information and requirements.

               7.9 No Inconsistent Agreements. The Company will not enter into
any agreement, the provisions of which conflict with or adversely affect the
rights of the Warrantholder under this Section 7, without the prior written
consent of the Warrantholder.

        8. Assignment; Exchange of Warrant. Subject to compliance with
applicable securities laws, and delivery of such representations and warranties
as shall reasonably be requested by the Company, this Warrant, and the rights
evidenced hereby, may be transferred by any registered holder hereof (a
"Transferor") with respect to any or all of the shares. On the surrender for
exchange of this Warrant, with the Transferor's endorsement in the form of
Exhibit B attached hereto (the Transferor Endorsement Form"), to the Company,
the Company at its expense but with payment by the Transferor of any applicable
transfer taxes) will issue and deliver to or on the order of the Transferor
thereof a new Warrant or Warrants of like tenor, in the name of the Transferor
and/or the transferee(s) specified in such Transferor Endorsement Form (each a
"Transferee"), calling in the aggregate on the face or faces thereof for the
number of shares of Common Stock called for on the face or faces of the Warrant
so surrendered by the Transferor.

        9. Replacement of Warrant. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this Warrant and, in the case of any such loss, theft or destruction of this
Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender and cancellation of this Warrant, the Company at its
expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

        10. Warrant Agent. The Company may, by written notice to the each holder
of the Warrant, appoint an agent having an office in New York, NY for the
purpose of issuing Common Stock (or Other Securities) on the exercise of this
Warrant pursuant to Section 1, exchanging this Warrant pursuant to Section 8,
and replacing this Warrant pursuant to Section 9, or any of the foregoing, and
thereafter any such issuance, exchange or replacement, as the case may be, shall
be made at such office by such agent.

        11. Transfer on the Company's Books. Until this Warrant is transferred
on the books of the Company, the Company may treat the registered holder hereof
as the absolute owner hereof for all purposes, notwithstanding any notice to the
contrary.

        12. Specific Performance. The Warrantholder, in addition to being
entitled to exercise all rights provided herein or granted by law, including
recovery of damages, will be entitled to specific performance of its right under
this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions
of this Warrant and hereby agrees to waive the defense in any action for
specific performance that a remedy at law would be adequate.

                                      -16-

<PAGE>   22
        13. Notices, etc. All notices and other communications from the company
to the holder of this Warrant shall be mailed by first class registered or
certified mail, postage prepaid, at such address as may have been furnished to
the Company in writing by such holder or, until any such holder furnishes to the
Company an address, then to, and at the address of, the last holder of this
Warrant who has so furnished an address to the Company.

        14. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be construed and enforced in accordance with and
governed by the laws of California. Any dispute relating to this Warrant shall
be adjudicated in the State of California. The headings in this Warrant are for
purposes of reference only, and shall not limit or otherwise affect any of the
terms hereof. The invalidity or unenforceability of any provision hereof shall
in no way affect the validity or enforceability of any other provision.

        IN WITNESS WHEREOF, the Company has executed this Warrant under seal as
of the date first written above.

                                        RNETHEALTH.COM, INC.

                                        By: /s/ WILLIAM MOSES
                                            --------------------
                                        Title: President & CEO
                                               -----------------

Witness:

/s/ [SIGNATURE ILLEGIBLE]
-----------------------------------

                                      -17-
<PAGE>   23

                                    Exhibit A

                              FORM OF SUBSCRIPTION
                   (To be signed only on exercise of Warrant)

TO: RNETHealth.com, Inc.

The undersigned, the holder of the within Warrant, hereby irrevocably elects to
exercise this Warrant for, and to purchase thereunder, (i)     shares of Common
Stock (as defined in the Warrant) and herewith makes payment of $      therefor,
or (ii)______ shares of Common Stock and hereby exercises the Cashless Exercise
Right pursuant to Section 1.4 of the Warrant and hereby surrenders warrants to
purchase a total of______ shares of Common Stock and requests that the
certificates for such shares be issued in the name of, and delivered to whose
address is______.

Dated:
      ----------------

                                ------------------------------------------------
                                (Signature must conform to name of holder as
                                specified on the face of the Warrant)

                                ------------------------------------------------
                                (Address)

                                      -18-
<PAGE>   24

                                                                       Exhibit B

                         FORM OF TRANSFEROR ENDORSEMENT
                   (To be signed only on transfer of Warrant)

               For value received, the undersigned hereby sells, assigns, and
transfers unto the person(s) named below under the heading "Transferees" the
right represented by the within Warrant to purchase the percentage and number of
shares of Common Stock (as defined in the Warrant) to which the within Warrant
relates specified under the headings "Percentage Transferred" and "Number
Transferred," respectively, opposite the name(s) of such person(s) and appoints
each such person Attorney to transfer its respective right on the books of
RNETHealth.com, Inc. or any successor thereof with full power of substitution in
the premises.

================================================================================
Transferees                   Percentage                     Number
                             Transferred                 Transferred
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

================================================================================

Dated:_______________,__

                                ------------------------------------------------
                                (Signature must conform to name of holder as
                                specified on the face of the warrant)

Signed in the presence of:

----------------------------    ------------------------------------------------
         (Name)                                   (address)

                                ------------------------------------------------
ACCEPTED AND AGREED:                              (address)
[TRANSFEREE]

----------------------------
        (Name)

                                      -19-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}]]